Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A. is a specialty pharmaceutical company based in Liège, Belgium, incorporated in 2012. It operates in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. Its products include Maxigesic IV for post-operative pain, Podofilox gel for external genital and perianal warts, Sotalol IV for atrial fibrillation and life-threatening ventricular arrhythmias, and Valacyclovir oral suspension for herpes virus infections. The company also develops Alenura for painful bladder syndrome, Aspirin IV for acute coronary syndrome, and other product candidates, and has collaboration agreements with FHP BV, Pleco Therapeutics, Vaneltix Pharma, Inc., and AFT Pharmaceuticals.